Mucostop
Product description:
Nutritional Information
Serving Size: 2 capsules
Amount Per Capsule:
Amylase Thera-blend 14,850 DU, Protease Thera-blend 45,000 HUT, Glucoamylase 50 AG, Betaglucanase 60 BGU, Lipase Thera-blend 500 FCCFIP, Alpha-Galactosidase 100 GalU, Cellulase Thera-blend 400 CU, Xylanase 550 XU, Seaprose 15 Mg, Pectinase w/ Phytase 350endo-Pgu, Hemmicellulase 30 HCU, Invertase 5 INVU
This product contain(s) no fillers.
This product contain(s)s a blend of enzymes formulated to break down mucous and reduce histamine.
The active ingredient is a potent mucolytic enzyme which has been studied for its effectiveness at reducing mucus and is combined with proteases and amylases blended to assist in overcoming the symptoms often associated with sinus and chest congestion.
Recommended Usage of MucoStopÖ Mucolytic Enzyme Formula Suggested Use: Two capsules, three times a day on an empty stomach.
Children and sensitive individuals: One capsule, three times a day on an empty stomach.
Store in a cool dry place. Keep out of reach of children.
MucoStopÖ Mucolytic Enzyme Formula:
Break Down Mucus. Mucus is defined as the clear viscid secretion of the mucus membranes, consisting of mucin, epithelial cells and leukocytes.
Enzymes classified as proteolytic (breaks down protein) and mucolytic (breaks down mucus) are beneficial at breaking down mucus.
Proteolytic enzymes are enzymes that break down proteins. Not all proteases, however, can break down all proteins. For example, a protease that is an effective digester of food protein will not be a good protease for mucous protein. The mucous protein requires an enzyme classified as proteolytic and mucolytic (breaks down mucous). Seaprose stands alone in this category.
Seaprose has at least six separate studies to support the effect it has on individuals with bronchial and sinus mucus as well as inflammatory issues. In one study it stated: Eight days after the end of treatment with seaprose, there was still a significant beneficial effect on the viscoelasticity of mucus and a sort of post-mucolytic effect can be postulated. The enzyme Seaprose also had anti-inflammatory action and since in chronic bronchitis there are variable degrees of inflammations, its beneficial long-lasting effect could also be ascribed to this concomitant action.
*This statement has not been evaluated by the Food and Drug Administration. This Product is not intended to diagnose, treat, cure or prevent any disease.
|
